StockData
CEL SCI Corp logo

CEL SCI Corp (CVM) income statement

CVMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.38−0.47 (-25.41%)

Close on Nov 18, 2026Market cap $24.27MP/E –Yield –

See a number that looks wrong?